Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - MEDIFAST INCv461286_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - MEDIFAST INCv461286_ex31-1.htm
EX-23.1 - EXHIBIT 23.1 - MEDIFAST INCv461286_ex23-1.htm
EX-21.1 - EXHIBIT 21.1 - MEDIFAST INCv461286_ex21-1.htm
10-K - FORM 10-K - MEDIFAST INCv461286_10k.htm

 

Exhibit 32

 

CERTIFICATION PURSUANT TO

 

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Medifast, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I Daniel R. Chard, Chief Executive Officer and I Timothy G. Robinson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of the operations of the Company.

 

By: /s/ Daniel R. Chard  
  Daniel R. Chard  
  Chief Executive Officer  
  March 16, 2017  
     
By: /s/ Timothy G. Robinson  
  Timothy G. Robinson  
  Chief Financial Officer  
  March 16, 2017